Table 4.
Comorbidities in women with symptoms suggestive of OAB by geographic location
| Characteristic | Algeria (n = 286)a | Egypt (n = 345)a | Jordan (n = 328)a | Lebanon (n = 276)a | Total (n = 1235) |
|---|---|---|---|---|---|
| Any comorbidity, n (%) | 132 (46.1) | 207 (60.0) | 143 (43.6) | 122 (44.2) | 604 (48.9) |
| Chronic constipation, n (%) | 34 (11.9) | 23 (6.7) | 9 (2.7) | 21 (7.6) | 87 (7.0) |
| Hypertension, n (%) | 68 (23.8) | 149 (43.2) | 105 (32.0) | 76 (27.5) | 398 (32.2) |
| Diabetes, n (%) | 45 (15.7) | 112 (32.5) | 75 (22.9) | 40 (14.5) | 272 (22.0) |
| Depression, n (%) | 27 (9.4) | 18 (5.2) | 7 (2.1) | 21 (7.6) | 73 (5.9) |
| Neurologic condition, n (%) | 19 (6.6) | 10 (2.9) | 6 (1.8) | 20 (7.2) | 55 (4.5) |
OAB overactive bladder
aTotal number of women with symptoms suggestive of OAB in each country